HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Tag: vaccine
-
Pfizer-BioNTech vaccine becomes the first vaccine to receive full FDA validation
The vaccine by Pfizer-BioNTech is the first vaccine that has been lincensed for COVID-19. The mRNA vaccine has shown to prevent 95 percent of COVID-19 during the clinical trials and can be administered in people aged 16 and older. It has also been given emergency use authorisation for use in adolescents in December last year. The two dose vaccine can be given…
-
ZyCoV-D : FIRST VACCINE FOR CHILDREN IN INDIA
Zydus Cadila’s DNA based vaccine ZyCoV-D becomes the first vaccine to receive emergency use authorization for children above 12 years of age. The three-dose vaccine has an efficacy rate of 66.6 per cent as per the trials conducted across the nation. Zydus’ needle free vaccine is only the second vaccine that is being produced in…
-
MODERNA TO USE mRNA FOR HIV AND CANCER AFTER COVID-19
Moderna has developed several drugs with its cost and time effective mRNA technology that are currently undergoing trials for HIV, cancer, heart diseases and genetic disorders that could potentially lead to a paradigm shift in the way medicines are developed and manufactured. The company currently has vaccines for 10 viruses in trials including one for…
-
INDIA ADMINISTERED OVER 32 CRORE DOSES, OVERTAKES US
Health ministry on Monday informed that as many as 32.8 crore doses of Covid-19 vaccines have been administered since the start of the vaccination drive that began from January 16. Out of these, one crore healthcare workers took the first dose and 72 lakh got the second dose as well. Following a new policy, India has…
-
NINE EUROPEAN COUNTRIES APPROVE INDIAN VACCINE COVISHIELD FOR GREEN PASS
European countries including, Austria, Germany, Slovenia, Greece, Estonia, Iceland, Ireland and Spain, and Switzerland have approved the Covishield COVID-19 vaccine for ‘Green Pass’. This comes after India has asked the European countries to allow entry to Indians vaccinated with Covishield or Covaxin. The Green Pass has been rolled out on July 1 to facilitate free…
-
ZYDUS CADILA’S VACCINE TO BE JUST AS EFFECTIVE WITH A TWO- DOSE REGIMEN
Highlights: Fifth vaccine to be authorized in India. Now effective with two doses. Company to manufacture 120M doses a year. If approved, it could be World’s first plasmid DNA shot. Zydus Cadila, a leading Indian Pharmaceutical company is seeking approval from the DCGI for the EUA of its Covid-19 vaccine candidate, ZyCoV-D. It is the…
-
SII TO SUPPLY 20 CRORE COVAVAX DOSES BY DEC 2021
The Maryland based company, Novavax’s covid-19 vaccine candiate, named Covavax in India is all set to be launched in August-September this year in association with the Pune based Serum Institute of India. The vaccine has shown 90% efficacy in the clinical trials conducted in the U.S. With U.S. easing the availability of the key raw…
-
FIRST DEATH FOLLOWING COVID-19 VACCINATION
A 68 year old man has died after being fully vaccinated with the covishield vaccine in the month of March due to anaphylaxis, which is considered as a severe allergic reaction that could happen post vaccination. In a report submitted by the AEFI Committee, it has been reported that the cause of death is a…
-
HOW LIKELY IS THE THIRD WAVE IN INDIA?
Several speculations are doing the rounds regarding the possibility of a third wave and if children are at a risk of getting infected in the subsequent wave. There is a lot of misinformation involved; however certain things need to be understood and implemented accurately so that we can look towards a foreseeable post pandemic future…
-
NEW AUSTRALIAN COVID VACCINE TO COMPLETELY PREVENT COVID-19 TRANSMISSION
An Adelaide based company, Vaxine Pty Ltd has successfully developed a COVID vaccine, COVAX-19 that holds the ability to completely prevent the covid-19 virus transmission in non-immune individuals. No other vaccine in the world has been yet found to show such promising results. COVAX-19 vaccine is a subunit vaccine based on synthetic protein produced using…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila